Ewha Womans University Medical Center
| República da Coreia | Turquia | Áustria | |
| Tratamento com células estaminais para hipertensão pulmonar | - | de $12,000 | de $55,000 |
| Aférese de LDL | - | de $1,650 | - |
A Bookimed não adiciona taxas extras aos preços de tratamento de Hipertensão pulmonar. As tarifas vêm das listas oficiais de preços das clínicas. O pagamento é feito diretamente na clínica na chegada ao país.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais no tratamento de Hipertensão pulmonar e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de tratamento de Hipertensão pulmonar.
O Hospital Severance — o maior hospital multidisciplinar da Coreia do Sul. Foi o primeiro no país a receber a prestigiosa acreditação americana pela qualidade do tratamento — JCI.
A especialização do Severance — oncologia, check-up (exame de saúde), cirurgia da coluna, cirurgia cardíaca e oftalmologia.
As conquistas do hospital incluem a primeira cirurgia cardíaca robótica na Coreia e a primeira implantação na Ásia de um disco espinhal artificial na região cervical.
Anualmente, o Hospital Severance recebe para tratamento mais de 1 000 000 de pacientes internados, dos quais 30 000 são estrangeiros.
O Hospital Gangnam Severance é o maior hospital multidisciplinar de Seul, Coreia do Sul.
Especialização — oncologia, neurocirurgia, neurologia, cardiologia e check-up (exame abrangente).
A clínica foi uma das primeiras em Seul a obter a acreditação americana Joint Commission International. Isso confirma a conformidade com os padrões internacionais de segurança no tratamento e o uso de métodos modernos.
Entre as conquistas do centro médico — o primeiro transplante de pulmão na Coreia do Sul.
Dr. Oh Dong Joo is a cardiologist. He specializes in coronary artery disease, valvular heart disease, heart failure, hypertension, and atrial fibrillation.
MD and PhD, Korea University. Professor of Cardiology, Korea University. Cardiology Fellow, Emory University. Clinical Instructor, Cornell University.
Leadership: Chairman, Korean Society of Cardiology. President, Korean Society of Interventional Cardiology. President, Korean Chapter of the ACC. Director, Cardiovascular Research Institute, Korea University.
Publications: 386 total. 242 SCI-indexed international papers.
Dr. Kyung-Hee Kim, MD, PhD, is Director of the Heart Transplantation Center and Head of Cardiology at Incheon Sejong Hospital. She earned her MD, MS, and PhD at Seoul National University College of Medicine. She completed international fellowships, including research at the Mayo Clinic.
Her expertise includes advanced heart failure, transplant evaluation and management, mechanical circulatory support (VAD, ECMO), pulmonary hypertension, complex cardiomyopathies, and genetic, valvular, and adult congenital heart disease.
She leads multidisciplinary cardiac care. She develops clinical protocols and education programs and contributes to research and guideline development in pulmonary hypertension and heart failure. She serves on the AHA Clinical Cardiology Membership Committee.
Specialized pulmonary hypertension (PH) programs in South Korea are primarily located within major tertiary university hospitals in Seoul. These centers, including Asan Medical Center and Severance Hospital, utilize multidisciplinary teams of cardiologists and pulmonologists. They provide advanced diagnostics like right-heart catheterization and specialized pulmonary vascular therapies.
Bookimed Expert Insight: While many search for a standalone pulmonary hypertension clinic, our data shows top Korean care is often found within large specialized departments. For instance, Dr. Kyung Hee Kim at Sejong Hospital leads heart transplantation and specializes specifically in pulmonary hypertension. Choosing a center with high heart or lung transplant volumes often ensures access to the most experienced vascular specialists.
Patient Consensus: Patients emphasize that seeking care at major Seoul university hospitals is vital for accessing specialized PH medications and precise right-heart catheterization. They note it is important to confirm the hospital has a dedicated pulmonary vascular specialist rather than just a general cardiology department.
Balloon Pulmonary Angioplasty (BPA) is available in South Korea at specialized cardiovascular centers. Major institutions like Severance Hospital and Asan Medical Center provide this interventional treatment for patients with chronic thromboembolic pulmonary hypertension (CTEPH). These centers use multidisciplinary teams to manage inoperable or residual cases.
Bookimed Expert Insight: While BPA is widely discussed, top-tier Korean centers like Asan Medical Center prioritize high-volume surgical expertise. Asan performs 45% of South Korea’s heart transplants and maintains a 90% success rate for organ procedures. This volume-to-outcome correlation suggests that patients should prioritize centers handling the highest daily inpatient loads, such as Severance with 1.6 million annual outpatients.
Patient Consensus: Patients emphasize finding specialized CTEPH centers because general clinics may not offer BPA or pulmonary endarterectomy. They also note that a formal workup at a high-volume facility can often change a patient's eligibility from inoperable to surgical candidates.
Top South Korean hospitals assign dedicated multidisciplinary teams to pulmonary hypertension patients. These centers typically coordinate care through pulmonologists and cardiologists. Facilities like Asan Medical Center and Seoul National University Hospital employ comprehensive teams to manage complex cases and advanced treatment protocols.
Bookimed Expert Insight: Clinical data shows a high concentration of expertise in Seoul, where hospitals like Asan Medical Center handle 45% of the nation's heart transplants. For patients, this means choosing a major Seoul center ensures a team with higher procedural volume. These teams are more likely to have established protocols for managing right-heart strain and specialized infusions compared to smaller regional clinics.
Patient Consensus: Patients note that care in large Korean hospitals is highly structured around a main specialist. They emphasize the importance of asking for a dedicated nurse coordinator to help manage complex testing and medication schedules between visits.
Patients should expect a multi-disciplinary evaluation involving JCI-accredited facilities in Seoul. Specialists use echocardiograms and right heart catheterization to confirm the diagnosis. The process identifies the specific cause of breathlessness among 5 clinical groups. Most diagnostic pathways conclude within 1 week at major Korean centers.
Bookimed Expert Insight: While many hospitals offer basic cardiology, Asan Medical Center performs 45% of heart transplants in South Korea. This volume suggests deep expertise in complex cases like advanced pulmonary hypertension. Choosing a center with high transplant volumes often ensures access to more experienced surgical teams for chronic clot removal.
Patient Consensus: Patients note the evaluation is a broad sorting process to find the specific cause of fatigue and swelling. They emphasize that while basic tests might look normal, specialists often continue investigating if symptoms persist during walking.
South Korea offers most modern pulmonary hypertension therapies, including recently approved agents like Winrevair and Opsynvi. While oral and inhaled options are widely available, intravenous epoprostenol remains a significant gap. Patients typically access advanced regimens at JCI-accredited academic centers in Seoul.
Bookimed Expert Insight: While drug availability is high, patients should focus on centers like Asan Medical Center. It handles over 65,000 operations yearly and performs 45% of Korea's heart transplants. This high volume often ensures faster access to the latest pharmaceutical protocols and multidisciplinary specialist teams.
Patient Consensus: Patients note that while medications are available in Seoul, insurance and reimbursement rules often dictate actual access. Bringing a detailed treatment history is essential for specialists to navigate these local prescription requirements.
Follow-up visits in South Korea occur 2 to 4 weeks after starting pulmonary hypertension therapy. Specialists at JCI-accredited centers in Seoul monitor drug tolerance and clinical response. These sessions include repeat echocardiography, bloodwork, and functional walk tests to ensure patient safety and dose accuracy.
Bookimed Expert Insight: South Korea's top cardiovascular centers, like Asan Medical Center, handle 45% of the country's heart transplants. This massive volume translates into highly standardized follow-up protocols. Patients benefit from the BESTcare digital system at centers like Seoul National University Bundang Hospital. This technology prevents medical errors during complex medication adjustments.
Patient Consensus: Patients note that initial visits are very data-heavy and require bringing a detailed symptom log. They emphasize that feeling better doesn't mean skipping tests, as objective results can change silently.